@FiercePharma: $GSK buoyed by early numbers on Anoro, Breo DTC campaigns. More | Follow @FiercePharma
@EricPFierce: Manufacturing plant cost baked into $2.5B Biogen CEO says it will cost to develop Alzheimer's drug. Item | Follow @EricPFierce
@CarlyHFierce: What's in a (drug) name? We asked the #FierceMadness champs. Article | Follow @CarlyHFierce
> GlaxoSmithKline ($GSK) said it would hire 150 new workers in Costa Rica to expand its business services operations there. Report
> Takeda Pharmaceutical will take a $2.7 billion charge against fiscal 2014 earnings to cover its $2.4 billion agreement to settle liability cases over its diabetes drug Actos. Report
> Ariad Pharmaceuticals ($ARIA) CEO Harvey Berger will retire as part of a deal with activist investor Sarissa Capital Management. Report
> France's Ipsen said sales rose to 350 million euros in the first quarter, up from 305.9 million euros a year ago, with specialty drug sales up 10% to 12% for the period. Report
> Teva Pharmaceutical ($TEVA) rolled out its version of the injectable thrombin inhibitor Argatroban. Release
Medical Device News
@FierceMedDev: NuVasive gains on $14M DOJ settlement over improper Medicare, Medicaid claims. Story | Follow @FierceMedDev
@VarunSaxena2: Drug testing company Cordant raises $12.8M as it seeks to be fragmented industry's one-stop shop. More | Follow @VarunSaxena2
@EmilyWFierce: #France's Labco looks to make market entree with €545 million IPO. Article | Follow @EmilyWFierce
> Philips ramping up CT scan production following €100M quality improvement plan at Cleveland facility. More
> Kaiser backs startup in $12.5M round to speed healthcare data integration. Story
> NuVasive gains on $14M DOJ settlement over improper Medicare, Medicaid claims. Article
Biotech News
@FierceBiotech: Activists get their way as Ariad CEO Berger steps down. Article | Follow @FierceBiotech
@JohnCFierce: I asked CRISPR Tx CEO Novak if he was prepping an IPO. (Answer: all options open) Felt damn silly even asking, but you have to these days. | Follow @JohnCFierce
@DamianFierce: Zymoquizyme got robbed. RT @CarlyHFierce What's in a (drug) name? We asked the #FierceMadness champs. More | Follow @DamianFierce
> Amgen adding 100 researchers in Cambridge as biotechs scout for 1,000-plus. More
> Celgene bets $30M on a Versant-backed cancer startup. News
> Celgene deepens its Agios ties with an $80M option deal. Story
Biotech Research News
> Mayo Clinic study finds a potential Achilles' heel for HER2-positive cancer. Story
> Better than RNAi? Emory team modifies CRISPR-Cas9 tech for viral infections. News
> Yale collaborators use gene editing tech to fix a cystic fibrosis mutation. Article
> International team opens a 'new frontier' in diabetes research. More
> Google's Calico continues its partnering romp on aging R&D with Buck collaboration. More
Diagnostics News
> Researchers show Adaptive's next-gen sequencing tech can diagnose recurrent Hodgkin lymphoma. Story
> Veracyte unveils $40M private placement to generate cash for R&D. Article
> Biocartis charges ahead with $109M IPO to fuel product development. More
> Drug testing company Cordant raises $12.8M as it seeks to be fragmented industry's one-stop shop. News
> Roche charges ahead with diagnostics R&D after sealing Foundation deal. Report
Pharma Marketing News
> Time for an asthma check, doc? AstraZeneca-sponsored EHR reminders will tell you. More
> GSK buoyed by early numbers on Anoro, Breo DTC campaigns. News
> Merck could be in for big Januvia boost, thanks to 'completely balanced' heart data. Report
> AbbVie says disappointing Viekira sales numbers are misleading. Article
> Pharma earns failing marks for integrity, but it beats advertising. Story
And Finally... Just two weeks of increased high-fructose corn syrup consumption had major--and negative--effects on cholesterol and triglyceride levels, a new study reveals. Report